roche

Blueprint, Roche take on Lilly with FDA approval for RET cancer drug Gavreto

This post was originally published on this siteBlueprint Medicines and partner Roche have won FDA approval for RET inhibitor Gavreto to challenge Eli Lilly’s first-to-market Retevmo.

Read More

Roche gets emergency approval for combination flu, COVID-19 test

This post was originally published on this siteRoche said Sept. 4 it has received emergency authorization from the FDA for its nasal swab test that detects the flu and COVID-19 and differentiates

Read More

Roche receives US emergency approval for coronavirus vs. flu test

This post was originally published on this siteZURICH (Reuters) – Drugmaker Roche (ROG.S) on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug

Read More

Regeneron’s Deal With Roche to Make Covid Antibody ‘Should Add Credibility to This Program’

This post was originally published on this siteRegeneron Pharmaceuticals announced a deal with rival drugmaker Roche Holding to manufacture Regeneron’s experimental Covid-19 antibody

Read More

Roche and Regeneron Team Up on Covid-19 Antibody Treatment

This post was originally published on this siteHere’s what you need to know about the impact of Covid-19 to navigate the markets today. • Pharmaceutical companies Roche and Regeneron

Read More

Regeneron enlists Roche to help make Covid-19 drug

This post was originally published on this siteRoche Holding AG has agreed to help manufacture and distribute a promising investigational drug for Covid-19 being developed by Regeneron

Read More

Roche, Regeneron link up on COVID-19 antibody cocktail

This post was originally published on this siteZURICH (Reuters) – Regeneron and Roche said on Wednesday they will collaborate on an investigational antibody cocktail against COVID-19, with

Read More

Roche’s Soliris rival Enspryng bags FDA approval

This post was originally published on this siteRoche’s neuromyelitis optica spectrum disorder (NMOSD) drug Enspryng has scored US Food and Drug Administration (FDA) approval, setting up a

Read More

Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab

This post was originally published on this siteRoche’s batch of phase 3 tests of its experimental GI drug etrolizumab has not gone to plan, with “mixed results” highlighting a

Read More

FDA approves Roche’s new spinal muscular atrophy drug

This post was originally published on this siteRoche Holding AG ROG, -0.27% said Friday that the Food and Drug Administration had approved Evrysdi, a treatment for spinal muscular atrophy in

Read More